EP 1173199 A1 20020123 - RAS ONCOGEN p21 PEPTIDE VACCINES
Title (en)
RAS ONCOGEN p21 PEPTIDE VACCINES
Title (de)
IMPFSTOFFE BASIEREND AUF RAS ONKOGEN p21 PEPTIDEN
Title (fr)
VACCINS A BASE DE PEPTIDES p21 RAS ONCOGENIQUE
Publication
Application
Priority
- NO 0000142 W 20000428
- NO 992102 A 19990430
Abstract (en)
[origin: WO0066153A1] The invention relates to synthetic peptide mixtures which elicit T cellular immunity, for use in cancer vaccines and compositions for anti-cancer treatment. Preferred peptides are RAS p21 (5-21, 49-73 and 52-70) mutant peptides and in particular the mutants G12A, G12C, G12D, G12R, G12S, G12V, G13D, Q61H, Q61K, Q61L and Q61R.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 14/82 (2006.01)
CPC (source: EP US)
A61K 39/001164 (2018.08 - EP US); A61P 35/00 (2018.01 - EP); C07K 14/82 (2013.01 - EP); A61K 39/00 (2013.01 - EP); A61K 2039/57 (2013.01 - EP)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0066153 A1 20001109; AR 023806 A1 20020904; AU 4438900 A 20001117; CA 2372187 A1 20001109; EP 1173199 A1 20020123; JP 2002543149 A 20021217; NO 309798 B1 20010402; NO 992102 D0 19990430; NO 992102 L 20001031
DOCDB simple family (application)
NO 0000142 W 20000428; AR P000102059 A 20000428; AU 4438900 A 20000428; CA 2372187 A 20000428; EP 00925746 A 20000428; JP 2000615037 A 20000428; NO 992102 A 19990430